Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). ZeroFox Protection is a commercial digital risk protection tool by ZeroFox. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: we never sell rankings.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Security teams protecting brand reputation and executive visibility across social media and the broader internet will get the most from ZeroFox Protection, which monitors 180+ platforms and catches impersonation and deepfakes that traditional perimeter tools completely miss. The automated takedown capability through its Global Disruption Network means threats disappear without waiting for manual coordination with platforms. Skip this if your priority is internal asset discovery or endpoint protection; ZeroFox is external-only and won't help you map what's running inside your network.
Tool that immunizes Windows systems against critical vulnerabilities
Digital risk protection platform for brand, domain, exec & social threats
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs ZeroFox Protection for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
ZeroFox Protection: Digital risk protection platform for brand, domain, exec & social threats. built by ZeroFox. Core capabilities include Brand protection across 180+ digital platforms, Executive impersonation and deepfake detection, Domain and subdomain monitoring..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. ZeroFox Protection differentiates with Brand protection across 180+ digital platforms, Executive impersonation and deepfake detection, Domain and subdomain monitoring.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). ZeroFox Protection is developed by ZeroFox. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
360 High-Risk Vulnerability Immunization Tool V2.0 and ZeroFox Protection serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox